| Primary |
| Drug Use For Unknown Indication |
51.8% |
| Gastrointestinal Infection |
9.4% |
| Prophylaxis Against Transplant Rejection |
7.1% |
| Sepsis |
5.9% |
| Pneumonia |
4.7% |
| Prophylaxis |
4.7% |
| Cellulitis |
3.5% |
| Pneumonia Aspiration |
3.5% |
| Urinary Tract Infection |
2.4% |
| Abdominal Abscess |
1.2% |
| Abdominal Infection |
1.2% |
| Ileus |
1.2% |
| Lower Respiratory Tract Infection |
1.2% |
| Product Used For Unknown Indication |
1.2% |
| Respiratory Disorder |
1.2% |
|
| Neutropenia |
20.0% |
| Pyrexia |
11.4% |
| Thrombocytopenia |
8.6% |
| Drug Ineffective |
5.7% |
| Gastrointestinal Perforation |
5.7% |
| Pancytopenia |
5.7% |
| Urinary Incontinence |
5.7% |
| Angioedema |
2.9% |
| Blood Bilirubin Increased |
2.9% |
| Blood Immunoglobulin E Increased |
2.9% |
| Depressed Level Of Consciousness |
2.9% |
| Dysphagia |
2.9% |
| Dyspnoea |
2.9% |
| Haematoma |
2.9% |
| Haemolysis |
2.9% |
| Hepatic Enzyme Increased |
2.9% |
| Jaundice Cholestatic |
2.9% |
| Laryngeal Oedema |
2.9% |
| Leukocytosis |
2.9% |
| Loss Of Consciousness |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
47.9% |
| Drug Use For Unknown Indication |
13.2% |
| Gangrene |
13.2% |
| Renal Transplant |
4.1% |
| Agranulocytosis |
3.3% |
| Device Related Infection |
3.3% |
| Metabolic Disorder |
3.3% |
| Respiratory Disorder |
2.5% |
| Cellulitis |
1.7% |
| Diabetes Mellitus |
1.7% |
| Lung Neoplasm Malignant |
1.7% |
| Mycobacterial Infection |
1.7% |
| Antibiotic Prophylaxis |
0.8% |
| Cardiac Disorder |
0.8% |
| Prophylaxis |
0.8% |
|
| Thrombocytopenia |
28.6% |
| Hyperkalaemia |
9.5% |
| Perivascular Dermatitis |
9.5% |
| Acute Pulmonary Oedema |
4.8% |
| Bacteraemia |
4.8% |
| Heart Rate Abnormal |
4.8% |
| Medication Error |
4.8% |
| Oliguria |
4.8% |
| Rash |
4.8% |
| Septic Shock |
4.8% |
| Swelling Face |
4.8% |
| Toxic Epidermal Necrolysis |
4.8% |
| Urine Output Decreased |
4.8% |
| Vasculitis |
4.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
52.0% |
| Drug Use For Unknown Indication |
18.1% |
| Multiple Myeloma |
3.1% |
| Evidence Based Treatment |
2.4% |
| Pain |
2.4% |
| Prophylaxis |
2.4% |
| Antifungal Prophylaxis |
2.2% |
| Anxiety |
1.7% |
| Breast Cancer |
1.7% |
| Colony Stimulating Factor Prophylaxis |
1.7% |
| Hypertension |
1.7% |
| Reflux Gastritis |
1.7% |
| Constipation |
1.3% |
| Pneumonia |
1.3% |
| Pyrexia |
1.3% |
| Colon Cancer |
1.1% |
| Glycogen Storage Disease Type Ii |
1.1% |
| Prophylaxis Against Transplant Rejection |
1.1% |
| Nausea |
0.9% |
| Acute Myeloid Leukaemia |
0.7% |
|
| Weight Decreased |
12.9% |
| Vision Blurred |
10.0% |
| Vomiting |
10.0% |
| Neuropathic Ulcer |
5.7% |
| Pyrexia |
5.7% |
| Vertigo |
5.7% |
| X-ray Abnormal |
5.7% |
| Cholecystitis Acute |
4.3% |
| Protein Total Decreased |
4.3% |
| Sepsis |
4.3% |
| Syncope |
4.3% |
| Thrombocytopenia |
4.3% |
| Asthenia |
2.9% |
| Febrile Neutropenia |
2.9% |
| Feeling Abnormal |
2.9% |
| Hypersensitivity |
2.9% |
| Leukocytosis |
2.9% |
| Liver Function Test Abnormal |
2.9% |
| Renal Failure |
2.9% |
| Skin Infection |
2.9% |
|
